TMO
January 31, 2024 - AI Summary
Undervalued by 28.5% based on the discounted cash flow analysis.
Market cap | $227.94 Billion |
---|---|
Enterprise Value | $256.30 Billion |
Dividend Yield | $1.4386 (0.24%) |
Earnings per Share | $15.59 |
Beta | 0.95 |
Outstanding Shares | 381,716,323 |
Avg 30 Day Volume | 1,492,870 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 37.78 |
---|---|
PEG | 1248.56 |
Price to Sales | 5.36 |
Price to Book Ratio | 5.0 |
Enterprise Value to Revenue | 6.03 |
Enterprise Value to EBIT | 35 |
Enterprise Value to Net Income | 42 |
Total Debt to Enterprise | 0.14 |
Debt to Equity | 0.78 |
No data
No data
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Its Mission is to enable our customers to make the world healthier, cleaner and safer. Whether the customers are acceleratin...